A network of 13 African countries has joined forces with global researchers to launch the largest clinical trial of potential Covid-19 treatments on the continent. The Anticov study, involving Antwerp’s Institute of Tropical Medicine and international research institutions, aims to identify treatments that can be used to treat mild and moderate cases of Covid-19 early and prevent spikes in hospitalisation that could overwhelm fragile and already overburdened health systems in Africa. The clinical trial will be carried out at 19 sites in 13 countries and led by doctors from African countries. The initiative emerged after calls for responses to the coronavirus better tailored to the developing world and the challenges of often underfunded healthcare systems. The study will test the efficacy of treatments in 2,000 to 3,000 mild-to-moderate patients in Burkina Faso, Cameroon, Ivory Coast, the Democratic Republic of the Congo, Equatorial Guinea, Ethiopia, Ghana, Guinea, Kenya, Mali, Mozambique, Sudan, and Uganda, with the aim of identifying treatments that can prevent progression of coronavirus to severe disease and also limit transmission.
SOURCE: THE GUARDIAN
More Stories
Economic Perks of Growing Cycling Culture in North Africa
The Bank of Uganda Lowers Limits on the Value of Cheque Payments to Promote e-payments
Four Industrial Policy Regimes that have Shaped Africa
Ex Standard Bank Leader Cleared in Mozambique Price Fixing
Zanzibar and Pemba are about to Become a Test Site for a Mobile Internet Network
East Africa’s Mineral Deposits at the Centre of Future-facing Commodities
A Scramble for Controlling Interest in Nigeria’s Oldest Bank
Top Risks Facing South Africa
New Scheme to Save Zimbabwe’s Botched Land Reform
The First Floating LNG Facility is Deployed in the Deep Waters of the African Continent
The EU Lifts Air Travel Bans on Southern African States
Senegal’s Illustrious Portfolio of Architecture